Eleven new secoiridoid aglycones involving unusual C 9 -skeleton: swerimilegenins A-F (1-6); bis-C 9 -skeleton: swerimilegenin G (7); and C 10 -skeleton: swerimilegenins H−K (8−11), as well as six known ones, were isolated from the low-polarity part of the traditional Chinese herb medicine Swertia mileensis. Their structures were determined by extensive spectroscopic data and X-ray diffraction. Biogenetically, swerimilegenin A (1) belonged to 10-nor-secoiridoid, and swerimilegenins B-F (2-6) were 1-nor-secoiridoids. Erythrocentaurin (12) and gentiogenal (15) showed moderate anti-HBV activity on HepG 2.2.15 cell line in vitro.
Introduction
Secoiridoids, are biogenetically derived from the cleavage of the cylcopentane ring of iridiods (generally between C-7 and C-8), and represent a large and still expanding group of monoterpenoids. Secoiridoids are widely present in mainly in Gentianales, Dipsacales, Cornales and Oleaceae. 1, 2 They have attracted significant interest from scientists for their diverse bioactivities, and conferred a diverse array of actions such as antiviral, cardiovascular, choleretic, hypoglycemic, antiinflammatory and purgative activities, and chemotaxonomic significance. 3 Secoiridoids consistently have a hemiacetal hydroxy group at C-1 position, which is unstable and apt to be glycosylated, thus most of the secoiridoids from natural resources are secoiridoid glycosides. 4 According to the carbon numbers involved in the aglycone part, secoiridoids can be classified into three main types: I) the normal skeleton with ten carbons; II) skeletons with more than ten carbons in the aglycone part; and III) skeletons with less than ten carbons. Presently, quite a few cases of secoiridoids other than C 10 skeleton have been reported. [5] [6] [7] Subsequently, the discovery of more secoiridoid aglycones with dissimilar skeletons will help to formulate a greater understanding of these compounds.
Previous investigations of Swertia mileensis ('Qing-Ye-Dan' in Mandarin), which is a well-known traditional Chinese herb, endemic to the Yunnan province and documented in every edition of the Chinese Pharmacopoeia from 1977-2010, has shown that secoiridoid glycosides, xanthones and triterpenoids were their active constituents. [8] [9] [10] As an ongoing search for anti-hepatitis B virus (anti-HBV) active compounds from natural resources, our recent investigation on the active part of S. mileensis resulted in a series of novel lactones, swerilactones A-O and swerilactosides A-C. [11] [12] [13] [14] [15] [16] [17] From a biosynthetic perspective, swerilactones A and B (C 18 skeleton) were derived from two C 9 secoiridoids, and swerilactones H-K (C 29 skeleton) were condensed by two C 10 and one C 9 secoiridoids. In addition, swerilactone G and swerilactosides A and B also contained the characteristic C 9 secoiridoid moieties in their structures. The above analysis suggests that S. mileensis may be rich in secoiridoid aglycones, especially for the unusual C 9 skeletons. Secoiridoids without glycosylation should be present in the low-polarity part of S. mileensis, however this part was ignored in the previous investigation, for its lowcontent and less-activity. Therefore, further investigation was focused on secoiridoid aglycones and was performed on the low-polarity part of S. mileensis, resulting in eleven new (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , as well as six pre-existing compounds (12) (13) (14) (15) (16) (17) . This paper will discuss their isolation, structural elucidation, and anti-HBV properties on HepG 2.2.15 cell line in vitro. and 1631 cm −1 ) absorptions. Therefore, four residual carbons (three O-bearing methylenes and one methine) required an additional ring to fulfill the unsaturation. The connectivity of O-C(8)-C(9)-C(1)-O was constructed by the 1 H-1 H COSY experiment (H-8/H-9/H-1), of which C-9 was proposed to be attached with C-5 by HMBC correlations from H-1 and H-8 to C-5 ( Figure 1 ). In HMBC spectrum, correlations from δ H 4.43 and 4.29 (H-3) to δ C 149.5 (C-5), 163.0 (C-11) and 66.5 (C-1) suggested that C-3 was directly linked to C-4 and further cyclized with C-1 by an oxygen atom. The configuration at C-9 was determined as R-form based on its optical rotation ([α] 18 D -12.4 ) and in comparison to the known compounds with the similar chiral center. 18, 19 Thus, the structure of compound 1 was determined and named as swerimilegenin A.
Compound 2 was assigned the molecular formula of C 9 H 14 O 3 by HREIMS which showed [M] + at m/z 170.0944 (calcd. 170.0943), with three degrees of unsaturation. The existence of hydroxy and carbonyl groups was verified by IR absorptions at 3430 and 1711 cm -1 . Nine carbons involving three quaternary ones, five methylenes and one methyl were detected in the 13 C NMR (DEPT) spectrum. The characteristic signals at δ C 166.2 (s, C-11), 156.8 (s, C-5), 126.2 (s, C-4), 65.5 (t, C-7) and 28.6 (t, C-6) enabled the α,β-unsaturated δ-lactone moiety. A propyl group was proposed at C-5 based on 1 H-1 H COSY (H-10/H-8/H-9) and HMBC experiments (H-9/C-4, C-6 and H-8/C-5). One remaining oxygenated methylene (C-3) was recognized with a hydroxmethyl group and assigned at C-4 according to the HMBC correlations of H-3/C-4 and C-5. Thus, the structure of compound 2 was constructed.
Compound 3 possessed the molecular formula of In order to determine the stereochemistry of C-3 and C-8, a ROESY experiment was performed, however the key correlation of H-8 or H-10 with H-3 was not detected. This phenomenon is frequently encountered in secoiridoids whose structure contains a six-member ring fused with a δ-lactone fragment. The connection of C( In addition, compound 7, the dehydrated dimer of 4, was also obtained and unambiguously determined by X-ray single crystal diffraction. Compounds 4 and 7 had the almost identical NMR spectral data and similar specific rotation value (-2.06° for 4, about half of -6.65° for 7) indicating the same stereochemistry.
Compound 5 was proposed the molecular formula of C 10 H 14 O 4 based on positive HRESIMS, 14 mass units (CH 2 ) higher than swerimilegenin D (4). Its 1 H and 13 C NMR spectroscopic data were similar to those of 4 except for an additional methoxy group (δ H 3.48, δ C 55.7). With the aid of HMBC analysis, the methoxy group was deduced at C-3 by the correlation of OMe with C-3. Similar to swerimilegenin D, no correlation between H-3 (or OMe) and H-8 (or H-10) was detected in the ROESY experiment due to the W configuration. The stereocenters of C-3 and C-8 in compound 5 were deduced to be the same as those of 4 by comparing their coupling constant in 1 H NMR spectrum and [α] D values.
Compound 6 was designated the molecular formula of C 10 H 12 O 5 by positive HRESIMS ([M + Na] + , as detected at m/z 235.0586, calcd. for 235.0582). A methoxy group was speculated by the ion peak at m/z 181 (M + -OMe) in the EIMS spectrum. Its 1 H and 13 C NMR data were similar to those of 5, except for the additional carbonyl group (196.6, s) instead of methylene [δ C 36.8 (t, C-9)] in 5. The C(9)=O was evidenced based on the HMBC correlations of H-10/C-9, H-8/C-9 and C-5. Similar to compounds 4 and 5, neither H-8/H-3 nor Me-10/H-3 was detected in its ROESY spectrum due to the stable W configuration. The stereochemistry of compound 6 was proposed to be the same as compounds 4 and 5 by the coupling constant (J H-10/H-8 = 6.5 Hz) and optical Only nine carbons and 11 protons were displayed in the 13 C and 1 H NMR spectra, indicating a symmetrical skeleton. Its 1 H and 13 C NMR spectral data were almost identical with those of 4, indicating the similar structures. The above analysis together with its molecular formula of C 18 H 22 O 7 (18 mass units less than two molecules of 4) suggested that compound 7 should be the dehydrated dimer of 4, which was finally confirmed by extensive 2D NMR experiment and X-ray single crystal diffraction (Figure 3 ).
Compound 8 possessed the molecular formula of C 10 H 12 O 4 in accordance with the ion peaks of M + at m/z 196 in EIMS and [M + Na] + at m/z 219.0641 in HRESIMS. The presence of OH and C=O groups was evidenced by the absorption bands at 3362 and 1699 cm -1 in IR spectrum. An obvious α,βunsaturated δ-lactone fragment was revealed from its 1 H and 13 C NMR spectroscopic data ( Table 2 ). In addition, one CH 3 CH=C moiety was proposed to be linked with C-5 and C-1 from the HMBC correlations of H-8 with C-5, H-6 with C-9 and H-1 with C-5 and C-8. The HMBC correlations of H-3 with C-4, C-5 and C-1 revealed the linkage of C(4)-C(3)-O-C(1). The Z-form of the double bond between C-8 and C-9 was determined by the correlation of H-8 with H-6 in the ROESY spectrum.
Compound 9 had the molecular formula of C 11 H 14 O 4 as a result of a positive HRESIMS experiment, with an additional CH 2 moiety compared to compound 8. Its IR, UV and NMR spectroscopic data were similar to 8, except for an additional methoxy group. In HMBC spectrum, the correlations of OCH 3 /C-1 and H-1/OCH 3 indicated that the methoxy group was located at C-1 position. Finally, its structure was determined by an X-ray single crystal diffraction experiment. Compound 10 was proposed with a molecular formula of C 10 H 14 O 4 by HREIMS at m/z 198.0897. The IR spectrum displayed the absorption bands at 3472, 1679, 1595 and 1404 cm -1 denoting the presence of OH, C=O and C=C groups. Its NMR spectroscopic data was close to that of dihydroepinaucledal (14) , indicating a similar structure. From its 1 H-1 H COSY and HMBC experiments, compound 10 was established the same planar structure as 14. Therefore, their 1 H and 13 C NMR spectral differences (Table 3) Compound 11 possessed the molecular formula of C 10 H 14 O 4 identical with swerimilegenin J from HRESIMS. The same planar structures of 11 with 10 and 14 were constructed based on extensive 1 H-1 H COSY and HMBC analysis. In the ROESY spectrum, the correlations of H-5 with H-1 and H-8, and H-9 Table 2 
. 1 H and 13 C NMR data for compounds 6-9 (δ in ppm, J in Hz)
NO. with H-10 manifested the α-orientation of H-5, H-8 and hydroxymethyl (C-1), and the β-orientation of H-9 and Me-10.
The known dihydroepinaucledal (14) was determined by comparing its NMR data with that of a previous report 20 and further confirmed by a 2D NMR experiment (see Electronic Supplementary Material). The other known compounds were determined as erythrocentaurin (12), 21 gentiolactone (13), 22 gentiogenal (15), 23 secostrychnosin (16) 24 and angelone (17) 5 by comparing their spectroscopic data to existing report data.
In order to evaluate their anti-HBV properties, namely inhibiting the secretions of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), as well as HBV DNA replication, the isolates were assayed on HepG 2.2.15 cell line in vitro (Table 4 ). Most of the tested compounds exhibited low activity and cytotoxicity at the highest tested concentration, except for erythrocentaurin and gentiogenal. Erythrocentaurin could inhibit the HBsAg secretion and HBV DNA replication with the IC 50 values of 1.39 ± 0.54 and 0.96 ± 0.45 mM, respectively. Gentiogenal showed activity inhibiting the secretion of HBsAg and HBeAg with the IC 50 values of 3.92 ± 0.82 and 2.99 ± 0.72 mM.
Previously, most of the secoiridoids isolated from Swertia plants were secoiridoid glycosides and always contained a C 10 aglycone part. Interestingly, this investigation resulted in eleven new secoiridoid aglycones including unusual C 9skeleton (1-6), bis-C 9 -skeleton (7) and C 10 -skeleton (8) (9) (10) (11) from the low-polarity part of S. mileensis. Structurally, compound 1 belonged to 10-nor-secoiridoid, and compounds 2-6 were attributed to 1-nor-secoiridoids, which further enriched the skeleton types of secoiridoids. It is concluded that diverse secoiridoid aglycones are contained in S. mileensis, although these compounds may be not corresponding to the anti-HBV activity in vitro.
Experimental Section
General Experimental Procedures. Melting points were measured on a SGWX-4B instrument (Shanghai Jingke, Shanghai, China). 1D and 2D NMR spectra were recorded on Bruker AV-400 NMR, DRX-500 or AVANCE III-600 spectrometers (Bruker, Bremerhaven, Germany) corrected by deuterated solvent signals. MS data was collected on LCMS-IT-TOF (Shimadzu, Kyoto, Japan) or VG Auto Spec-3000 (VG, Manchester, UK) spectrometers. IR (KBr) spectra was recorded on a Bruker Tensor 27 FT-IR (Bruker Optics GmbH, Ettlingen, Germany). UV data was collected on a Shimadzu UV-2401A spectrophotometer (Shimadzu, Kyoto, Japan). Extraction and Isolation. The air-dried and powered whole plant (5.0 kg) of S. mileensis was extracted with ethanol and condensed to provide a residue (1.3 kg). The residue was partitioned between water and petroleum ether (PE, 1 L × 2), ethyl acetate (EtOAc, 1 L × 3) and n-butanol (1 L × 3) successively. The EtOAc part (170 g) was chromatographed on silica gel column (2 kg, 110 mm id × 500 mm) eluted with CHCl 3 -MeOH to provide fractions A−J. Fraction A (29 g) was separated by silica gel column chromatography (CC, 300 g, 50 mm id × 240 mm) with an eluent of CHCl 3 -Me 2 CO system (0:100 → 50:50, v/v) to yield Frs. A 1 −A 5 . 11 Frs. A 1 and A 2 were combined based on TLC detection which displayed many identical spots both under UV detector and treated with H 2 SO 4 regent, and subjected to silica gel CC (200 g, 25 mm id  600 mm) eluted with CHCl 3 /MeOH gradient (100:0, 95:5, 90:10 and 80:20, with 2 L, respectively), to obtain three fractions A 1A -A 1C . Fraction A 1B (5 g) was separated by CHP20P MCI gel column chromatography (100.0 g, 25 mm id  300 mm) on a MPLC system eluted with MeOH/H 2 O (from 20:80 to 80:20, 10 L) to yield seven sub-fractions (Frs. A 1B-1 to A 1B-7 ). Fr. A 1B-1 (300 mg) was purified with a silica gel column (50 g, 25 mm id  150 mm) eluting with PE/acetone (from 80:20 to Anti-HBV Assay. The anti-HBV procedure was performed in accordance with our previous report. 15 Tenofovir (Lot No. 200904009 , purity > 97.6%) was used as the positive control, which was purchased from Jiangxi Chenyang Pharmaceutical Co. Ltd..
Electronic Supplementary Material
Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s13659-013-0059-y and is accessible for authorized users.
